widely used to identify apoptosis are light and electron microscopy,2-6 flow cytometry,7 and agarose gel electrophoresis.8 However, because of the small size and typically scattered distribution ofapoptotic cells and apoptotic bodies in spontaneous human tumours high magnification objectives are needed for studying apoptosis on routine light microscopy. Re- cently, the in situ end-labelling (ISEL) technique has been used to identify apoptosis in paraffin wax sections.9 10 The principle of ISEL is that the DNA of apoptotic cells becomes fragmented into regular nucleosome sized units, the overhanging 3'-OH ends of which can be identified by the immunohistochemical detection of enzymatically incorporated digoxygenin labelled triphosphates such as dUTP. [9] [10] [11] Although ISEL has been used to identify apoptosis in human tumours,"-14 there is very little data correlating ISEL findings with standard light and electron microscopic evaluation of apoptosis in tumours. We therefore examined the use of ISEL in the assessment of apoptosis in lung carcinomas, correlating the findings with semiquantitative and quantitative determination of apoptosis on routine light microscopy and with ultrastructural observations. 
Methods

Results
In all three tumour types apoptotic cells and apoptotic bodies were scattered among viable tumour cells and were often also concentrated in the non-viable rim of necrotic zones. Small cell undifferentiated carcinoma had more apoptosis than either squamous cell carcinoma or adenocarcinoma; apoptotic cells, with peripherally beaded or shrunken nodular condensed chromatin, and apoptotic bodies occurred in clusters among viable tumour cells, with no associated inflammatory response. The cytological detail of cells undergoing apoptosis was more clearly seen in semithin toluidene blue sections (fig 1) .
On ISEL, squamous cell carcinomas and adenocarcinomas showed moderate to strong staining of the shrunken nuclear chromatin in apoptotic cells. These cells usually had a perinuclear "halo" and often had cell membrane condensation (fig 2) . Some apoptotic cells and apoptotic bodies showed enhanced staining of the nuclear membrane with reduced or absent staining of the remainder of the nucleus. Occasional, apparently normal tumour cell nuclei were also labelled. A variable proportion of morphologically identifiable apoptotic cells and apoptotic bodies did not stain.
In small cell carcinomas apoptotic tumour cells predominantly showed an irregular nuclear membrane ISEL pattern (fig 3) . This ISEL pattern correlated closely with the morphology of apoptosis seen in toluidene blue (fig 1) and ultrathin sections (see later). Many apoptotic cells and apoptotic bodies were not labelled.
On ISEL, there was also weak cytoplasmic staining of tumour cells that had phagocytosed apoptotic tumour cells or lymphocytes. Macrophages showed cytoplasmic staining and necrotic cells showed homogeneous weak staining that differed from that seen in apoptotic cells (fig 4) . In necrotic zones apoptotic cells were seen in the non-viable rim and occasionally mixed with central necrotic tumour cells or polymorphs. Very scattered labelled apoptotic cells were identified within bronchiolar epithelium and in alveolar spaces in areas of bronchopneumonia distal to the tumour.
Apoptotic indices ranged from 0-1 to 5-4% (mean 1 3%) for adenocarcinoma, 0 04 to 7 9% (mean 2 3%) for squamous cell carcinoma and 5-4 to 14-0% (mean 10-9%) for small cell carcinoma. Semiquantitative assessment of apoptosis reflected apoptotic indices for each tumour type-for example, most adenocarcinomas had a score of 1 and five of Small cell carcinomas showed the spectrum of ultrastructural cellular alterations associated with apoptosis. In two cases tumour cells showed predominantly early apoptotic features with irregular peripheral subnucleolemmal or maze-like transnuclear condensation of granular osmiphilic chromatin ( fig 5) . The third case, which had less apoptosis, contained more uniformly osmiphilic apoptotic nuclei, interpreted as representing a later stage of apoptosis (fig 6) . Compared with small cell carcinoma there was minimal apoptosis in squamous cell carcinoma or adenocarcinoma. In both adenocarcinoma and squamous cell carcinoma occasional phagocytosed apoptotic bodies and tumour cells exhibiting late apoptotic changes (fig 7) were seen. One adenocarcinoma had rare tumour cells in early apoptosis. 
